Gao Sa Sa, Zhao Yongfang
Shi's Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Institute of Traumatology & Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
Osteoporos Int. 2023 Apr;34(4):627-639. doi: 10.1007/s00198-022-06593-7. Epub 2022 Nov 16.
The aim is to evaluate the effect of β-carotene for osteoporosis and provide quantitative evidence.
PubMed, Embase, Web of Science, and Cochrane Library were searched for eligible studies. Fifteen studies were included. Random-effect model was applied to pool the odds ratio (OR). The risk of osteoporosis and fracture were compared between low β-carotene intake group and high β-carotene intake group.
The intake of β-carotene was unassociated with the overall risk of osteoporosis [OR = 0.733, 95% Cl (0.528, 1.018), p = 0.064]. Subgroup analysis showed that the intake of β-carotene was negatively associated with the risk of osteoporosis in both male subgroup [OR = 0.7, 95% Cl (0.549, 0.893), I = 40.40%, p = 0.004] and female subgroup [OR = 0.684, 95% Cl (0.487, 0.960), I = 86.40%, p = 0.028]. There was also a negative association between β-carotene intake and osteoporosis in Asia subgroup [OR = 0.512, 95% Cl (0.403, 0.650), I = 0.00%, p = 0], whereas no association was observed in Western subgroup [OR = 1.107, 95% Cl (0.908, 1.350), I = 2.30%, p = 0.314]. In addition, random-effect model was adopted to pool the standard mean difference (SMD), and the results showed that β-carotene intake was positively associated with overall bone mineral density (BMD) [SMD = - 0.213, 95% Cl (- 0.391, - 0.034), I = 87.30%, p = 0.019]. Subgroup analysis showed that β-carotene intake was positively associated with BMD in Asian participants [SMD = - 0.394, 95% Cl (- 0.461, - 0.328), I = 0, p = 0], while unassociated in Western participants [SMD = - 0.047, 95% Cl (- 0.314, 0.219), I = 78.9%, p = 0.727].
β-carotene may improve BMD and reduce the risk of osteoporosis and fracture. However, these effects could vary by gender and race and need to be further validated by longitudinal studies.
评估β-胡萝卜素对骨质疏松症的影响并提供定量证据。
检索PubMed、Embase、Web of Science和Cochrane图书馆以查找符合条件的研究。纳入15项研究。应用随机效应模型合并比值比(OR)。比较低β-胡萝卜素摄入量组和高β-胡萝卜素摄入量组之间骨质疏松症和骨折的风险。
β-胡萝卜素的摄入量与骨质疏松症的总体风险无关[OR = 0.733,95% CI(0.528,1.018),p = 0.064]。亚组分析表明,在男性亚组[OR = 0.7,95% CI(0.549,0.893),I = 40.40%,p = 0.004]和女性亚组[OR = 0.684,95% CI(0.487,0.960),I = 86.40%,p = 0.028]中,β-胡萝卜素的摄入量与骨质疏松症风险呈负相关。在亚洲亚组中,β-胡萝卜素摄入量与骨质疏松症之间也存在负相关[OR = 0.512,95% CI(0.403,0.650),I = 0.00%,p = 0],而在西方亚组中未观察到相关性[OR = 1.107,95% CI(0.908,1.350),I = 2.30%,p = 0.314]。此外,采用随机效应模型合并标准均数差(SMD),结果表明β-胡萝卜素摄入量与总体骨密度(BMD)呈正相关[SMD = - 0.213,95% CI(- 0.391,- 0.034),I = 87.30%,p = 0.019]。亚组分析表明,β-胡萝卜素摄入量与亚洲参与者的BMD呈正相关[SMD = - 0.394,95% CI(- 0.461,- 0.328),I = 0,p = 0],而在西方参与者中无相关性[SMD = - 0.047,95% CI(- 0.314,0.219),I = 78.9%,p = 0.727]。
β-胡萝卜素可能改善骨密度并降低骨质疏松症和骨折的风险。然而,这些影响可能因性别和种族而异,需要通过纵向研究进一步验证。